Matera, Maria Gabriella
Rinaldi, Barbara
Calabrese, Cecilia
Belardo, Carmela
Calzetta, Luigino
Cazzola, Mario
Page, Clive
Funding for this research was provided by:
GlaxoSmithKline (Study 214746)
Article History
Received: 18 December 2023
Accepted: 26 January 2024
First Online: 28 February 2024
Declarations
:
: Not applicable.
: MGM participated as a faculty member and advisor in scientific meetings and courses under the sponsorship of ABC Farmaceutici, Almirall, AstraZeneca, Chiesi Farmaceutici, GlaxoSmithKline and Novartis, was a consultant to Chiesi Farmaceutici and GSK, and her department was funded by GSK and Novartis. CC received honoraria for lectures from AstraZeneca, GSK, Sanofi and Novartis, and support for attending meetings and/or travel received from AstraZeneca, GSK, Sanofi and Novartis. LC has participated as advisor in scientific meetings under the sponsorship of Boehringer Ingelheim and Novartis, received nonfinancial support from AstraZeneca, received a research grant partially funded by Chiesi Farmaceutici, Boehringer Ingelheim, Novartis, and Almirall; has been a consultant to ABC Farmaceutici, Edmond Pharma, Zambon, Verona Pharma, and Ockham Biotech; his department was funded by Almirall, Boehringer Ingelheim, Chiesi Farmaceutici, Novartis, and Zambon. MC participated as a faculty member and advisor in scientific meetings and courses under the sponsorship of Abdi Ibrahim, Alkem, Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, Cipla, Eurodrug, GSK, Glenmark, Lallemand, Mankind Pharma, Menarini Group, Mundipharma, Novartis, Pfizer, Recipharm, Sanofi, Teva, Verona Pharma and Zambon, and is or was a consultant to ABC Farmaceutici, AstraZeneca, Chiesi Farmaceutici, GSK, Lallemand, Novartis, Ockham Biotech, Recipharm, Verona Pharma and Zambon. CP has acted as a consultant to Eurodrug, Recipharm, Glycosynnovation and PrEP Biopharma, and also holds equity in Verona Pharma. BR and CB declare no conflict of interest.